Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 916542 Boston, MA
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$289,113
+$144,687 QoQ
Shares Held
27,746
+18.1% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 95 holders
Holding Since
Jun 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. RNAC ranks #108 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in RNAC

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $289,113 27,746
2026-03-31 $144,426 23,484
2024-09-30 $28,387 1,761
2023-03-31 $2,097,828 1,509,229
2022-12-31 $1,886,574 1,669,535
2022-09-30 $2,191,431 1,336,239
2022-06-30 $1,425,690 1,088,313
2022-03-31 $223,745 181,907
2021-12-31 $1,867,347 572,806
2021-09-30 $3,407,181 819,034
2021-06-30 $2,708,439 647,952
2021-03-31 $1,665,426 368,050
2020-06-30 $26,139 9,204